Tenet Healthcare director Roy Blunt reported routine equity-compensation transactions involving company common stock. He exercised 1,333 restricted stock units that were each the economic equivalent of one share of Tenet Healthcare common stock, receiving shares as part of the settlement.
In connection with this activity, he disposed of 493 shares back to the issuer at a price of $173.78 per share. After these transactions, Blunt directly owns 5,189 shares of Tenet Healthcare common stock. The filing reflects compensation-related settlements rather than open-market buying or selling.
TENET HEALTHCARE CORP reported initial holdings for Principal Accounting Officer John Michael Grooms on a Form 3. The filing shows unvested April 2026 time-based restricted stock units covering 2,584 shares of common stock, scheduled to vest in two equal installments on April 15, 2028 and April 15, 2029. These restricted stock units will be settled in shares of common stock when they vest.
Tenet Healthcare Corporation reported Q1 2026 net operating revenues of $5,368 million and net income of $906 million, up from $622 million a year earlier. Diluted earnings per share rose to $8.01 from $4.27 as margins improved.
Operating cash flow reached $1,641 million, supported by a $540 million contract termination payment from CommonSpirit Health under an Omnibus Agreement tied to Conifer. Ambulatory Care net operating revenues grew 10.6% to $1,320 million, while hospital admissions and adjusted admissions were roughly flat.
Tenet ended the quarter with $2,967 million in cash and long-term debt of $13,128 million, and repurchased 1.346 million shares for $318 million, leaving $1,172 million authorized for future buybacks. Management also highlights potential future pressures from U.S. healthcare policy changes, including the One Big Beautiful Bill Act.
Tenet Healthcare Corp ownership filing shows Vanguard Capital Management reports beneficial ownership of 4,582,013 shares of common stock, representing 5.26% of the class. The filing states Vanguard has sole dispositive power over 4,582,013 shares and sole voting power over 670,605 shares. The disclosure notes these holdings reflect securities managed across Vanguard affiliates and funds and that the position is reported on behalf of managed accounts and investment companies.
Tenet Healthcare reported strong first quarter 2026 results, with net income available to common shareholders of $702 million, or $8.01 per diluted share, up from $406 million, or $4.27, a year earlier. Net operating revenues rose to $5.37 billion from $5.22 billion.
Adjusted diluted EPS increased 10.6% to $4.82, while consolidated Adjusted EBITDA was essentially flat at $1.16 billion and a 21.6% margin. Results included $413 million of revenue and an approximate $40 million favorable non‑recurring pre‑tax impact from early conclusion of a Conifer contract with CommonSpirit Health.
Operating cash flow for the quarter was $1.64 billion, and adjusted free cash flow was $978 million. Tenet repurchased 1.35 million shares for $318 million and ended March 31, 2026 with a net debt to Adjusted EBITDA ratio of 2.24x. Full‑year 2026 guidance calls for net operating revenues of $21.5–$22.3 billion and Adjusted EBITDA of $4.49–$4.79 billion.
Tenet Healthcare Corporation is asking shareholders to vote at its May 27, 2026 virtual annual meeting on three items: electing 12 directors, approving executive pay on an advisory basis, and ratifying Deloitte & Touche LLP as auditor for 2026.
The proxy highlights strong 2025 performance, including a 21.4% adjusted EBITDA margin, an EBITDA leverage ratio of 2.25x and about $1.72B in free cash flow after noncontrolling interest distributions. Tenet repurchased 8.8 million shares for $1.4B and invested over $1B in capital projects while expanding its USPI ambulatory network and opening a new hospital.
At year-end 2025 Tenet employed roughly 99,000 people across 50 hospitals, 132 outpatient sites, and 559 ambulatory surgery locations. Executive pay is positioned as performance-based, with 2025 annual incentives funded at 200% of target and paid using individual performance multipliers, and long‑term incentives delivered mainly in performance-based RSUs.
Tenet Healthcare Corporation has entered into a Retirement Transition Agreement with Executive Vice President and Chief Information Officer Paola Arbour. She will retire from her CIO role effective December 31, 2026, then move to a part-time, non-executive position providing transition support through April 1, 2028.
After her full-time employment ends, Ms. Arbour will receive a weekly salary of $820, remain eligible for a 2026 bonus under the Annual Incentive Plan (but not for 2027), and her outstanding equity awards will continue to vest under existing terms. She will also continue participation in medical, dental and prescription benefit plans and keep vesting and service credit in the Executive Retirement Account through April 1, 2028. The agreement includes a general release of claims in favor of the company and requires a confirming release in 2028.
Tenet Healthcare Corporation announced leadership changes in its accounting function. Senior Vice President & Controller and Principal Accounting Officer R. Scott Ramsey will now retire effective April 30, 2026, and continue part-time with the company through March 31, 2028, to provide transition support.
Effective April 6, 2026, Tenet is appointing J. Michael Grooms, age 48, as Senior Vice President & Controller, and he will become Principal Accounting Officer on May 1, 2026. Under his offer letter, Grooms will receive a $475,000 base salary, a target cash bonus equal to 60% of salary, an initial $500,000 RSU grant, eligibility for a 2027 equity award of about $350,000, a $250,000 cash sign-on bonus, and relocation benefits.
The Vanguard Group filed Amendment No. 16 to a Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Tenet Healthcare Corp common stock as part of an internal realignment described under SEC Release No. 34-39538.
The filing states certain Vanguard subsidiaries will report beneficial ownership separately after the realignment dated 01/12/2026, and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those subsidiaries. The form is signed by Ashley Grim on 03/27/2026.